Ca<sup>2+</sup>-driven PDIA6 biomolecular condensation ensures proinsulin folding.
Nature Cell Biology
(2025)
27
1952
(doi: 10.1038/s41556-025-01794-8)
A Cathepsin B-Triggered CO-Releasing Molecule with a Non-toxic Metal Core for Targeted Tumor Delivery
Angew Chem Int Ed Engl
(2025)
e13808
(doi: 10.1002/anie.202513808)
A Cathepsin B‐Triggered CO‐Releasing Molecule with a Non‐Toxic Metal Core for Targeted Tumor Delivery
Angewandte Chemie International Edition
(2025)
e13808
(doi: 10.1002/anie.202513808)
A Cathepsin B‐Triggered CO‐Releasing Molecule with a Non‐Toxic Metal Core for Targeted Tumor Delivery
Angewandte Chemie
(2025)
e13808
(doi: 10.1002/ange.202513808)
Identification of potent high-affinity secondary nucleation inhibitors of Aβ42 aggregation from an ultra-large chemical library using deep docking.
Mol Syst Biol
(2025)
1
(doi: 10.1038/S44320-025-00159-5)
Escherichia coli with a 57-codon genetic code
Science (New York, N.Y.)
(2025)
390
eady4368
(doi: 10.1126/science.ady4368)
α-Synuclein driven cell susceptibility in Parkinson’s disease
(2025)
(doi: 10.21203/rs.3.rs-7375981/v1)
Serial amplification of tau filaments using Alzheimer's brain homogenates and C322A or C322S recombinant tau.
FEBS letters
(2025)
599
2768
(doi: 10.1002/1873-3468.70141)
Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue
Nature Biomedical Engineering
(2025)
1
(doi: 10.1038/s41551-025-01496-4)
Nanoscale profiling of evolving intermolecular interactions in ageing FUS condensates.
Commun Chem
(2025)
8
284
(doi: 10.1038/s42004-025-01659-z)
Advances in Proximity-Assisted Bioconjugation.
Accounts of chemical research
(2025)
58
2939
(doi: 10.1021/acs.accounts.5c00368)
Secondary nucleation of α-Synuclein drives Mitochondria dysfunctions and Lewy body formation in Parkinson’s Disease
(2025)
(doi: 10.1101/2025.09.17.676873)
Design of Tau Aggregation Inhibitors Using Iterative Machine Learning and a Polymorph-Specific Brain-Seeded Fibril Amplification Assay
Journal of the American Chemical Society
(2025)
147
35942
(doi: 10.1021/jacs.5c12812)
Tumour-specific STING agonist synthesis via a two-component prodrug system
Nat Chem
(2025)
1
(doi: 10.1038/s41557-025-01930-9)
Microglial activation and alpha-synuclein oligomers drive the early inflammatory phase of Parkinson’s disease
(2025)
(doi: 10.1101/2025.08.25.671921)
Rapid elongation drives the exceptionally fast aggregation of medin, the most common localized human amyloid
(2025)
(doi: 10.21203/rs.3.rs-6476074/v1)
α-Synuclein driven cell susceptibility in Parkinson’s disease
(2025)
(doi: 10.1101/2025.08.19.670819)
[2.2.1]Heterobicyclic Bromovinyl Sulfones for Thiol-Triggered Strategies in Linker Chemistry: Aza- vs Oxa-Norbornadienic Systems.
Bioconjug Chem
(2025)
36
2079
An unnatural base pair for the detection of epigenetic cytosine modifications in DNA.
Nat Chem
(2025)
17
1732
(doi: 10.1038/s41557-025-01925-6)
Structure-based Generation of a Secondary Nucleation Inhibitor in α-Synuclein Aggregation Using a Conditional Diffusion Model
(2025)
(doi: 10.1101/2025.08.16.670694)
Predicting Experimental Success in De Novo Binder Design: A Meta-Analysis of 3,766 Experimentally Characterised Binders
(2025)
(doi: 10.1101/2025.08.14.670059)
Correction: Modifying recombinant purple acid phosphatase using computational design.
European Biophysics Journal
(2025)
1
(doi: 10.1007/s00249-025-01792-6)
Classification of Tauopathies from Human Brain Homogenates through Salt-Modulated Tau Amplification
(2025)
(doi: 10.1101/2025.08.05.25331458)
A Charge-Driven Strategy for Covalent Modification and Modulation of Biomolecular Condensates.
J Am Chem Soc
(2025)
147
28558
(doi: 10.1021/jacs.5c06625)